Coronary artery disease is the most common form of heart disease and the leading cause of death in India and worldwide. It is also, in my experience as an interventional cardiologist at Hridhay Heart Center, Gajuwaka, Visakhapatnam, the condition that generates the most anxiety in patients and families, partly because of the fear the words heart disease carry, and partly because of the gap between what patients are told at the time of diagnosis and what they genuinely understand about what is happening to their heart, what the treatment involves, and what their life looks like on the other side. Across twenty years of cardiac practice, more than 11,000 patients, and a clinical background that includes DNB Cardiology from Narayana Hrudayalaya, Bengaluru, one of India's highest-volume cardiac centres, I have seen that patients who understand their disease make better decisions, take their medications more reliably, and achieve better long-term outcomes than those who do not. This guide is written to provide that understanding.
What Coronary Artery Disease Is: How Plaques Form and Why It Matters
Coronary artery disease occurs when the arteries that supply blood to the heart muscle itself become narrowed or blocked by the accumulation of atherosclerotic plaques inside their walls. Understanding this process, which begins earlier in life than most patients realise, is the foundation of understanding why the disease is both preventable and treatable.
The coronary arteries, the left anterior descending, the left circumflex, and the right coronary artery, with their many branches, supply oxygen-rich blood to every part of the heart muscle. When the heart muscle receives adequate blood, it contracts effectively, and the person feels no symptoms. Atherosclerosis, the disease process underlying coronary artery disease, begins with damage to the endothelium, the thin inner lining of the arterial wall. Risk factors including high blood pressure, high LDL cholesterol, diabetes, smoking, chronic stress, obesity, and physical inactivity all contribute to this endothelial injury. At the sites of injury, LDL cholesterol particles penetrate the arterial wall, where they are oxidised and trigger an inflammatory response. Macrophages, the scavenging white blood cells of the immune system, engulf the oxidised LDL and become foam cells that accumulate in the arterial wall, forming the fatty streak that is the earliest visible stage of atherosclerosis. Over years to decades, this accumulation grows. Smooth muscle cells migrate into the lesion. Calcium deposits. A fibrous cap forms over the lipid-rich core. The result is the atherosclerotic plaque.
There are two clinically critical behaviours of plaques. Stable plaques grow gradually and narrow the artery progressively, eventually producing symptoms when the coronary blood supply is inadequate for the demand the heart places on it during exertion. Unstable plaques, also called vulnerable plaques, have a thin fibrous cap over a large lipid core. When this cap ruptures, the lipid core is exposed to flowing blood, a clot forms rapidly over the ruptured surface, and the artery can occlude suddenly. This is the mechanism of acute myocardial infarction, the heart attack, and it is why heart attacks frequently occur without warning in people who had no prior exertional symptoms, because the vulnerable plaque that ruptures may not have been sufficiently obstructive to cause symptoms before it ruptured.
Angina Versus Heart Attack: Understanding the Spectrum
Coronary artery disease presents across a spectrum from completely asymptomatic atherosclerosis detected incidentally on imaging, to stable angina, to unstable angina, to acute myocardial infarction. Understanding where a patient sits on this spectrum determines the urgency and nature of treatment.
Stable angina is the predictable chest discomfort that occurs when exertion increases the heart's demand for blood beyond what the narrowed coronary arteries can supply. It is typically felt as a pressure, heaviness, squeezing, or tightness in the centre of the chest, often radiating to the left arm, jaw, or back, and it resolves within minutes of rest or with a nitrate tablet placed under the tongue. Stable angina is a signal that significant coronary narrowing exists and requires investigation, but it is not itself a heart attack. The coronary blood supply is restricted but not absent, and the heart muscle is stressed rather than damaged at the time of each episode.
Unstable angina occurs when a plaque becomes disrupted enough to produce a partially obstructing clot without fully occluding the artery. Angina occurring at rest, angina that is worsening in frequency or severity compared to a prior stable pattern, and new-onset angina are all presentations of unstable angina, which is a medical emergency requiring immediate hospital evaluation.
A heart attack occurs when coronary blood flow is completely or near-completely obstructed, usually by a clot forming over a ruptured plaque, and the heart muscle supplied by that artery begins to die. The degree of muscle loss depends on how long the artery remains blocked, which is why the central message in any discussion of heart attack is time. Every minute of ongoing occlusion extends the zone of irreversible muscle injury. The pain of a heart attack is typically more severe than angina, is not relieved by rest, and is often accompanied by sweating, breathlessness, nausea, or a sense of impending doom. But heart attacks also present atypically, particularly in people with diabetes, who may have blunted pain perception from diabetic neuropathy, and in women, who more frequently present with fatigue, breathlessness, and jaw pain without typical chest pressure. My clinical trial work on the association between HbA1c and acute coronary syndrome in patients with type 2 diabetes reflects the particular clinical importance of this diabetic presentation in the Visakhapatnam population, where diabetes prevalence is high and silent coronary disease is common.
Diagnosing Coronary Artery Disease: What Angiography Shows and Why It Matters
The pathway from symptoms to diagnosis of coronary artery disease begins with non-invasive investigations: an electrocardiogram that may show ischaemic changes, an echocardiogram that assesses the heart's pumping function and wall motion abnormalities, and a stress test that provokes ischaemia under controlled conditions to confirm that symptoms correlate with inadequate coronary flow. In many patients, these investigations are sufficient to confirm the diagnosis and guide management. But in patients requiring invasive evaluation, particularly those with significant angina, abnormal non-invasive testing, or acute coronary syndromes, coronary angiography is the definitive diagnostic procedure.
Coronary angiography, also called cardiac catheterisation, involves the introduction of a thin flexible catheter through the radial artery at the wrist, advancing it under X-ray guidance to the coronary arteries, and injecting iodinated contrast material that makes the coronary anatomy visible under X-ray fluoroscopy. The procedure typically takes 30 to 45 minutes. The patient lies on the catheterisation table, the wrist is numbed with local anaesthetic, and the catheter is introduced and advanced under X-ray guidance. The patient may feel a brief warmth when the contrast is injected but otherwise experiences no pain during the procedure itself. The resulting images show the coronary arteries in their full anatomy, revealing where narrowings or occlusions exist, how severe they are, and what the blood flow downstream from the lesion looks like.
The angiogram provides the roadmap from which all subsequent treatment decisions are made. It shows which vessels are affected, the location of the narrowings within each vessel, the percentage of luminal diameter reduction (a narrowing of 70 percent or more of the vessel diameter is generally considered haemodynamically significant), the length of each lesion, and critically, the characteristics of the lesion: whether it is concentric or eccentric, whether it is calcified, whether it involves a bifurcation point where the vessel divides, and whether it represents a chronic total occlusion, a vessel that has been completely blocked for more than three months.
Stenting Versus Bypass Surgery: How the Decision Is Made
When angiography reveals significant coronary disease, the treatment decision is between percutaneous coronary intervention, which is the catheter-based procedure of angioplasty and stenting, and coronary artery bypass grafting surgery. This decision is one of the most important in cardiology, and it is made through a combination of angiographic findings, clinical factors, and the patient's own preferences and circumstances.
For single-vessel disease or two-vessel disease without involvement of the left main coronary artery, angioplasty and stenting is generally the preferred approach: it is less invasive, requires no general anaesthesia, has a shorter recovery time, and produces equivalent outcomes to bypass surgery in appropriately selected patients. The procedure can often be performed at the same sitting as the diagnostic angiogram.
For more complex disease, including significant left main coronary artery disease, triple-vessel disease with reduced heart function, and anatomically complex lesions not well-suited to stenting, bypass surgery is typically preferred. Bypass surgery creates new pathways for blood to reach the heart muscle by grafting vessels from the chest wall or legs to bypass the blocked segments of the coronary arteries. It does not remove the blockages but routes blood around them. The SYNTAX score, a standardised angiographic scoring system, quantifies the complexity of coronary anatomy and helps guide the discussion between the interventional cardiologist and the cardiac surgeon, and in complex cases, a heart team discussion involving both specialists ensures that the treatment decision reflects the best available evidence for that specific patient's anatomy.
What Happens During Angioplasty and Stenting
When the decision is made to proceed with angioplasty and stenting, the procedure continues directly through the same catheter access at the wrist. A thin wire, finer than a human hair, is navigated across the narrowed segment of the coronary artery under X-ray guidance. This guidewire provides the track over which all subsequent devices are delivered.
A balloon catheter is advanced over the guidewire to the narrowed segment and inflated at high pressure to compress the plaque and expand the vessel lumen. This is balloon angioplasty. In most cases, a coronary stent, a small metal mesh scaffold, is then deployed at the same site to hold the vessel open permanently. Modern drug-eluting stents are coated with a medication that is released slowly into the vessel wall, suppressing the overgrowth of smooth muscle cells that can cause the treated segment to re-narrow, a process called in-stent restenosis. The result of successful stenting is restoration of normal or near-normal blood flow through the treated vessel, confirmed by repeat angiography and blood flow measurement after the stent is deployed.
Complex Coronary Interventions: Rotablation, Chronic Total Occlusions, and Bifurcation Stenting
A significant proportion of the patients who come to Hridhay Heart Center, Gajuwaka, have been told elsewhere that their coronary disease is too complex or too calcified for standard stenting. Complex coronary intervention is the specific clinical area in which my twenty years of interventional experience and my training at Narayana Hrudayalaya, one of India's busiest and most technically advanced cardiac centres, are most directly relevant.
Rotational atherectomy, or rotablation, is the technique used when coronary plaques are heavily calcified and cannot be adequately dilated by standard balloon inflation. A diamond-tipped rotating burr, spinning at up to 200,000 revolutions per minute, is advanced over the guidewire to the calcified lesion and passed through it, ablating the calcium and creating a channel that allows subsequent balloon and stent delivery. Rotablation does not remove all the plaque but modifies the calcium structure sufficiently to allow full stent expansion. Without adequate stent expansion, drug-eluting stents do not perform optimally and the risk of stent thrombosis and restenosis increases. Rotablation is the solution that converts an apparently untreatable calcified lesion into one that can be stented safely and effectively.
Chronic total occlusions, vessels that have been completely blocked for more than three months, represent perhaps the most technically challenging category of coronary intervention. The standard antegrade technique of crossing the occlusion with a guidewire from the upstream side fails in a significant proportion of cases. Retrograde techniques, in which the occluded vessel is accessed from its downstream end through collateral vessels that have developed to supply the territory beyond the block, require specialised wires, microcatheters, and a systematic approach that developed as a subspecialty within interventional cardiology over the past two decades. Successfully opening a chronic total occlusion restores blood flow to a territory that may have been ischaemic for months or years, with meaningful clinical benefit in appropriately selected patients.
Bifurcation lesions, narrowings at points where a major coronary artery branches into two vessels, present the challenge that treating one branch may compromise the other. Techniques including provisional stenting, where the main branch is stented first and the side branch addressed only if needed, and two-stent techniques with specific configurations such as the crush, the culotte, and the TAP technique for different anatomical situations, are selected based on the angle between branches, the size of the side branch, and whether the disease extends into the side branch.
After the Procedure: What Recovery Looks Like and What Medicines You Will Take
The immediate recovery from coronary angioplasty performed through the wrist is typically straightforward. Most patients are mobile within hours of the procedure, and in elective cases many are discharged home the same day or the following morning after a period of observation. The access site at the wrist is closed with a compression band that is removed over several hours. Patients are advised to avoid heavy lifting with the treated arm for a week but can otherwise resume light activities promptly.
The most critical aspect of recovery after coronary stenting is adherence to dual antiplatelet therapy, the combination of aspirin and a second antiplatelet agent such as clopidogrel or ticagrelor, which must be taken without interruption for at least twelve months after a drug-eluting stent and in some cases for longer. The stent, once deployed, needs time for the vessel wall to heal over its surface. During this healing period, the stent is at risk of acute thrombosis if the antiplatelet treatment is stopped. A patient who stops their dual antiplatelet therapy early, even for a seemingly minor procedure, faces a very high risk of catastrophic stent thrombosis and acute heart attack. This is the most important message I give every patient before they leave Hridhay Heart Center after a stenting procedure: the medications are not optional, and no elective procedure should be performed without discussing the antiplatelet medications with me first.
Beyond the antiplatelet agents, patients after coronary stenting typically require a statin for cholesterol management, a beta-blocker to reduce the heart's oxygen demand and protect against arrhythmia, an ACE inhibitor or ARB to reduce cardiac remodelling, and in patients with reduced heart function, additional agents as indicated. These are not temporary medications. They are the medical foundation of secondary prevention, and their benefit extends across the long term.
Secondary Prevention and Cardiac Rehabilitation: Protecting the Treated Heart
Coronary intervention treats the blockage. It does not cure the underlying disease. The atherosclerotic process that created the blockage continues in the vessels that were not treated, and can progress in the treated vessel as well if the risk factors that drove it are not controlled. Secondary prevention, the active management of all modifiable cardiovascular risk factors after a coronary event or intervention, is the clinical discipline that determines the long-term outcome.
The five pillars of secondary prevention after coronary artery disease are: smoking cessation (the single most impactful lifestyle intervention, which halves the risk of recurrent coronary events within a year of quitting), blood pressure control to below 130/80 mmHg, LDL cholesterol reduction to below 70 mg/dL with high-intensity statin therapy, diabetes control with HbA1c maintained as close to normal as safely achievable, and regular physical activity. My clinical research on the association between HbA1c and acute coronary syndrome outcomes reflects the specific importance of diabetes management in the secondary prevention of coronary events, and this is a particular focus in the Visakhapatnam patient population where type 2 diabetes affects a very large proportion of the people who present with coronary disease.
Cardiac rehabilitation, a supervised programme of graduated physical exercise combined with education about risk factor management and psychological support, is the evidence-based intervention that most consistently improves outcomes after a heart attack or coronary intervention. Studies have shown that cardiac rehabilitation reduces cardiovascular mortality by approximately 25 percent in the patients who complete it, yet it remains significantly underutilised, partly because patients fear that exercise will be dangerous for a heart that has just been treated. The fear is understandable but unfounded: supervised exercise, graduated appropriately to the individual's recovery, is cardioprotective, not harmful.
Returning to Work, Driving, and Normal Life: A Practical Guide for Visakhapatnam Patients
One of the most practical questions patients ask at Hridhay Heart Center after a coronary procedure is when they can return to their normal life, and the answer depends on what type of procedure was performed, the nature of the job, and whether the heart function was significantly affected by the event.
After elective coronary angioplasty and stenting for stable angina, most patients can resume desk work and light activity within one to two weeks. Driving is generally resumed after one to two weeks for private use, though this is guided by the patient's symptom resolution and the specific cardiac event. Physical labour requires a longer recovery and should be discussed individually.
After a heart attack, the recovery timeline is longer and depends significantly on how much heart muscle was affected. A small heart attack with preserved heart function may allow return to work within two to four weeks. A large heart attack that has reduced the heart's pumping function requires a more extended recovery, cardiac rehabilitation, and careful reassessment of function before heavy activity or work is resumed.
Sexual activity can typically be resumed when the patient can walk briskly without symptoms or breathlessness, which is usually within two to four weeks after an uncomplicated angioplasty, or four to six weeks after a heart attack. The energy expenditure of moderate sexual activity is equivalent to climbing two flights of stairs, and this is a useful practical guide for assessing readiness. Patients should inform their partner and have their glyceryl trinitrate (GTN) spray available but are not expected to permanently restrict this aspect of their life.
The follow-up schedule after coronary intervention at Hridhay Heart Center includes an outpatient review at four to six weeks after the procedure, then at six months, then annually. At each visit, medication adherence, risk factor control, and symptoms are reviewed, and echocardiography and other investigations are arranged as indicated. The long-term relationship between the patient and the cardiologist is not about the procedure that was performed. It is about the ongoing management of the disease that remains after the procedure.
To book a cardiology consultation with Dr. K Narayana Raju at Hridhay Heart Center, Gajuwaka, Visakhapatnam (Monday to Saturday, 4:00 PM to 7:00 PM), call +91 85999 56999.
Written by Dr. K Narayana Raju, MBBS (M S Ramaiah Medical College, Bengaluru), MD (Internal Medicine, Kasturba Medical College, Mangalore), DNB (Cardiology, Narayana Hrudayalaya, Bengaluru), Consultant Interventional Cardiologist, Hridhay Heart Center, Beside Eaters Stop Restaurant, Opposite Chinagantyada Bus Stop, Gajuwaka, Visakhapatnam, Andhra Pradesh 530026. 20+ years. 11,000+ patients. Phone: +91 85999 56999.
Related reading
Breaking Down Complex Coronary Blockages: When and Why Advanced Interventions Matter
Diabetes and Heart Disease: Why Indians With Type 2 Diabetes Are at Higher Coronary Risk
The Critical Role of Preventive Cardiology: Building a Heart-Healthy Future
Add a Comment